Show simple item record

dc.contributor.authorKatusiime, Christine
dc.contributor.authorOcama, Ponsiano
dc.contributor.authorKambugu, Andrew
dc.date.accessioned2022-04-30T18:41:35Z
dc.date.available2022-04-30T18:41:35Z
dc.date.issued2014
dc.identifier.citationKatusiime, C., Ocama, P., & Kambugu, A. (2014). Basis of selection of first and second line highly active antiretroviral therapy for hiv/aids on genetic barrier to resistance: a literature review. African Health Sciences, 14(3), 679-681. http://dx.doi.org/10.4314/ahs.v14i3.25en_US
dc.identifier.urihttp://dx.doi.org/10.4314/ahs.v14i3.25
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/3062
dc.description.abstractThe effectiveness of combination antiretroviral therapy (cART) continues to improve as treatment choices expand with the development of new antiretroviral agents and regimens. However, the successful long-term treatment of HIV/AIDS is under threat from the emergence of drug-resistant strains to multiple agents and entire drug classes.en_US
dc.language.isoenen_US
dc.publisherAfrican Health Sciencesen_US
dc.subjectGenetic barrieren_US
dc.subjectHighly active antiretroviral therapyen_US
dc.subjectHIV resistanceen_US
dc.titleBasis of selection of first and second line highly active antiretroviral therapy for hiv/aids on genetic barrier to resistance: a literature review.en_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record